|
1
|
Eom GH and Kook H: Posttranslational
modifications of histone deacetylases: Implications for
cardiovascular diseases. Pharmacol Ther. 143:168–180. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Frey N and Olson EN: Cardiac hypertrophy:
The good, the bad, and the ugly. Annu Rev Physiol. 65:45–79. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chang L, Kiriazis H, Gao XM, Du XJ and
El-Osta A: Cardiac genes show contextual SWI/SNF interactions with
distinguishable gene activities. Epigenetics. 6:760–768. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eom GH and Kook H: Role of histone
deacetylase 2 and its post-translational modifications in cardiac
hypertrophy. BMB Rep. 48:131–138. 2015. View Article : Google Scholar :
|
|
5
|
Trivedi CM, Luo Y, Yin Z, Zhang M, Zhu W,
Wang T, Floss T, Goettlicher M, Noppinger PR, Wurst W, et al: Hdac2
regulates the cardiac hypertrophic response by modulating Gsk3 beta
activity. Nat Med. 13:324–331. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kee HJ and Kook H: Roles and targets of
class I and IIa histone deacetylases in cardiac hypertrophy. J
Biomed Biotechnol. 2011:9283262011. View Article : Google Scholar
|
|
7
|
Kee HJ, Sohn IS, Nam KI, Park JE, Qian YR,
Yin Z, Ahn Y, Jeong MH, Bang YJ, Kim N, et al: Inhibition of
histone deacetylation blocks cardiac hypertrophy induced by
angiotensin II infusion and aortic banding. Circulation. 113:51–59.
2006. View Article : Google Scholar
|
|
8
|
Kong Y, Tannous P, Lu G, Berenji K,
Rothermel BA, Olson EN and Hill JA: Suppression of class I and II
histone deacetylases blunts pressure-overload cardiac hypertrophy.
Circulation. 113:2579–2588. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kee HJ and Kook H: Krüppel-like factor 4
mediates histone deacetylase inhibitor-induced prevention of
cardiac hypertrophy. J Mol Cell Cardiol. 47:770–780. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takuwa Y, Okamoto Y, Yoshioka K and Takuwa
N: Sphingosine-1-phosphate signaling and biological activities in
the cardiovascular system. Biochim Biophys Acta. 1781:483–488.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hait NC, Allegood J, Maceyka M, Strub GM,
Harikumar KB, Singh SK, Luo C, Marmorstein R, Kordula T, Milstien
S, et al: Regulation of histone acetylation in the nucleus by
sphingosine-1-phosphate. Science. 325:1254–1257. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Means CK and Brown JH:
Sphingosine-1-phosphate receptor signalling in the heart.
Cardiovasc Res. 82:193–200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
National Research Council (US) Committee
for the Update of the Guide for the Care and use of Laboratory
Animals. Washington (DC): National Academies Press (US); 2011
|
|
14
|
Takimoto E, Champion HC, Li M, Belardi D,
Ren S, Rodriguez ER, Bedja D, Gabrielson KL, Wang Y and Kass DA:
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and
reverses cardiac hypertrophy. Nat Med. 11:214–222. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu W, Zi M, Tsui H, Chowdhury SK, Zeef L,
Meng QJ, Travis M, Prehar S, Berry A, Hanley NA, et al: A novel
immunomodulator, FTY-720 reverses existing cardiac hypertrophy and
fibrosis from pressure overload by targeting NFAt (nuclear factor
of activated T-cells) signaling and periostin. Circ Heart Fail.
6:833–844. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cingolani OH, Yang XP, Cavasin MA and
Carretero OA: Increased systolic performance with diastolic
dysfunction in adult spontaneously hypertensive rats. Hypertension.
41:249–254. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma H, Gong H, Chen Z, Liang Y, Yuan J,
Zhang G, Wu J, Ye Y, Yang C, Nakai A, et al: Association of Stat3
with HSF1 plays a critical role in G-CSF-induced cardio-protection
against ischemia/reperfusion injury. J Mol Cell Cardiol.
52:1282–1290. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dolber PC, Bauman RP, Rembert JC and
Greenfield JC Jr: Regional changes in myocyte structure in model of
canine right atrial hypertrophy. Am J Physiol. 267:H1279–H1287.
1994.PubMed/NCBI
|
|
19
|
Sag CM, Santos CX and Shah AM: Redox
regulation of cardiac hypertrophy. J Mol Cell Cardiol. 73:103–111.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Knapp M: Cardioprotective role of
sphingosine-1-phosphate. J Physiol Pharmacol. 62:601–607. 2011.
|
|
21
|
Karliner JS, Honbo N, Summers K, Gray MO
and Goetzl EJ: The lysophospholipids sphingosine-1-phosphate and
lysophosphatidic acid enhance survival during hypoxia in neonatal
rat cardiac myocytes. J Mol Cell Cardiol. 33:1713–1717. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lecour S, Smith RM, Woodward B, Opie LH,
Rochette L and Sack MN: Identification of a novel role for
sphingolipid signaling in TNF alpha and ischemic preconditioning
mediated cardioprotection. J Mol Cell Cardiol. 34:509–518. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alvarez SE, Milstien S and Spiegel S:
Autocrine and paracrine roles of sphingosine-1-phosphate. Trends
Endocrinol Metab. 18:300–307. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fyrst H and Saba JD: An update on
sphingosine-1-phosphate and other sphingolipid mediators. Nat Chem
Biol. 6:489–497. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Strub GM, Maceyka M, Hait NC, Milstien S
and Spiegel S: Extracellular and intracellular actions of
sphingosine-1-phosphate. Adv Exp Med Biol. 688:141–155. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Spiegel S and Milstien S: Functions of a
new family of sphin-gosine-1-phosphate receptors. Biochim Biophys
Acta. 1484:107–116. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wendler CC and Rivkees SA:
Sphingosine-1-phosphate inhibits cell migration and endothelial to
mesenchymal cell transformation during cardiac development. Dev
Biol. 291:264–277. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Seto E and Yoshida M: Erasers of histone
acetylation: The histone deacetylase enzymes. Cold Spring Harb
Perspect Biol. 6:a0187132014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sekiguchi K, Yokoyama T, Kurabayashi M,
Okajima F and Nagai R: Sphingosylphosphorylcholine induces a
hypertrophic growth response through the mitogen-activated protein
kinase signaling cascade in rat neonatal cardiac myocytes. Circ
Res. 85:1000–1008. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Robert P, Tsui P, Laville MP, Livi GP,
Sarau HM, Bril A and Berrebi-Bertrand I: EDG1 receptor stimulation
leads to cardiac hypertrophy in rat neonatal myocytes. J Mol Cell
Cardiol. 33:1589–1606. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wei L: Lysophospholipid signaling in
cardiac myocyte hypertrophy. J Mol Cell Cardiol. 36:465–468. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nguyen-Tran DH, Hait NC, Sperber H, Qi J,
Fischer K, Ieronimakis N, Pantoja M, Hays A, Allegood J, Reyes M,
et al: Molecular mechanism of sphingosine-1-phosphate action in
Duchenne muscular dystrophy. Dis Model Mech. 7:41–54. 2014.
View Article : Google Scholar :
|
|
33
|
Nagahashi M, Takabe K, Liu R, Peng K, Wang
X, Wang Y, Hait NC, Wang X, Allegood JC, Yamada A, et al:
Conjugated bile acid-activated S1P receptor 2 is a key regulator of
sphingosine kinase 2 and hepatic gene expression. Hepatology.
61:1216–1226. 2015. View Article : Google Scholar :
|
|
34
|
Pearson R, Fleetwood J, Eaton S, Crossley
M and Bao S: Krüppel-like transcription factors: A functional
family. Int J Biochem Cell Biol. 40:1996–2001. 2008. View Article : Google Scholar
|
|
35
|
Yoshida T, Yamashita M, Horimai C and
Hayashi M: Kruppel-like factor 4 protein regulates
isoproterenol-induced cardiac hypertrophy by modulating myocardin
expression and activity. J Biol Chem. 289:26107–26118. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liao X, Haldar SM, Lu Y, Jeyaraj D,
Paruchuri K, Nahori M, Cui Y, Kaestner KH and Jain MK: Krüppel-like
factor 4 regulates pressure-induced cardiac hypertrophy. J Mol Cell
Cardiol. 49:334–338. 2010. View Article : Google Scholar : PubMed/NCBI
|
